Search
for
Sort by
Research 91–120 of 1000+
- The evaluation of IL-4 intron 3 VNTR and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with Alopecia Areata: a case-control study
- The role of lymphocytes in the development and treatment of alopecia areata
- ULBP3: a marker for alopecia areata incognita
- Carbamazepine-Induced Hair Loss
- Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study
- Erythematous cutaneous nodules caused by adulterated cocaine
- Drug-Induced Skin, Nail and Hair Disorders
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Recent advances in understanding of radiation-induced skin tissue reactions with respect to acute tissue injury and late adverse effect
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Evaluation of the Antioxidant and Cytotoxic Activities of Carthamus caeruleus L. Rhizome Extracts
- Suppression of Cutibacterium acnes-Mediated Inflammatory Reactions by Fibroblast Growth Factor 21 in Skin
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Cutaneous manifestations associated with immune checkpoint inhibitors
- STRESS AND AGING*
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Catalytic Antibodies in Norm and Systemic Lupus Erythematosus
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
- A new strategy to modulate alopecia using a combination of two specific and unique ingredients.
- Kerion Celsi caused by Microsporum gypseum in a Chinese child, a case report
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors